Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition.
about
Molecular mechanisms of renal blood flow autoregulationPlasminogen activator inhibitor type 1 up-regulation is associated with skeletal muscle atrophy and associated fibrosisPAI-1-dependent endothelial cell death determines severity of radiation-induced intestinal injuryPost-irradiation approaches to treatment of radiation injuries in the context of radiological terrorism and radiation accidents: a review.Association analysis of ADPRT1, AKR1B1, RAGE, GFPT2 and PAI-1 gene polymorphisms with chronic renal insufficiency among Asian Indians with type-2 diabetes.Practical considerations of the pharmacology of angiotensin receptor blockers.Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy.Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodelingPlasminogen activator inhibitor-1 and the kidney.Sulodexide ameliorates early but not late kidney disease in models of radiation nephropathy and diabetic nephropathy.The role of plasminogen activator inhibitor-1 and angiotensin-converting enzyme gene polymorphisms in bronchopulmonary dysplasia.Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditionsRadioprotectors in radiotherapy.Potential methods to prevent interstitial fibrosis in renal disease.PAI-1 antagonists: the promise and the peril.Origin of interstitial fibroblasts in an accelerated model of angiotensin II-induced renal fibrosis.Epistatic effects of polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systems on plasma t-PA and PAI-1 levels.Transforming growth factor-beta-dependent and -independent pathways of induction of tubulointerstitial fibrosis in beta6(-/-) mice.Inhibition of Thrombin-Activated Fibrinolysis Inhibitor Increases Survival in Experimental Kidney Fibrosis.Role of the angiotensin II type-2 receptor in radiation nephropathy.Mechanisms of progression of chronic kidney diseaseEssential role of plasminogen activator inhibitor type-1 in radiation enteropathyOxidative stress, plasminogen activator inhibitor 1, and lung fibrosisThe orphan nuclear receptor SHP attenuates renal fibrosis.Plasminogen activator inhibitor-1 antagonist TM5441 attenuates Nω-nitro-L-arginine methyl ester-induced hypertension and vascular senescence.A conceptual framework for the molecular pathogenesis of progressive kidney disease.Sp1-like activity mediates angiotensin-II-induced plasminogen-activator inhibitor type-1 (PAI-1) gene expression in mesangial cells.A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis.Renal fibrosis: not just PAI-1 in the sky.Chronic oxidative stress as a mechanism for radiation nephropathy.Pivotal role of PAI-1 in a murine model of hepatic vein thrombosis.Sphingomyelinase-like phosphodiesterase 3b mediates radiation-induced damage of renal podocytes.Ang II enhances tubular cell Ets-1 expression and associated down stream signaling is mediated through AT1 receptors.The fibrinolytic system attenuates vascular tone: effects of tissue plasminogen activator (tPA) and aminocaproic acid on renal microcirculation.Effect of delapril-manidipine combination vs irbesartan-hydrochlorothiazide combination on fibrinolytic function in hypertensive patients with type II diabetes mellitus.Prevention of fibrosis in experimental colitis by captopril: the role of tgf-beta1.A profibrotic effect of plasminogen activator inhibitor type-1 (PAI-1) in the heart.Intratubular Renin-Angiotensin System in Hypertension.Plasminogen activator inhibitor-1 serves an important role in radiation-induced pulmonary fibrosis
P2860
Q26825286-520ED82A-77C0-4355-9AA3-80BE67BBF22BQ28566526-50124F20-AE0E-4BDE-ABCD-A5AB6658FE5DQ28730314-A3131FC6-827B-4188-B52D-C30BD4F50451Q30233314-96F94F7A-2428-4D54-8583-B584C7D694FCQ33547739-867117AA-6937-4F6C-8A70-309C81BDD0CBQ33650699-982C7834-85AF-42A9-8966-3E7D258D248AQ33793187-08A60AAC-DAAF-49E3-BE1C-212439A19F50Q33930863-4490A93D-60C1-4E01-B996-1CF662474CCEQ33960082-47F341E0-A541-44CC-A7BF-DA106D9F4D77Q33988752-CFFF3EDD-E10D-4C77-9675-3C3859655E8DQ34211497-6D79996D-6312-4887-8D19-44CB146B818FQ34217461-27371F65-2AD6-4C8F-817D-7DABC44C8158Q34274559-E0D1AA7F-2F14-44EB-8920-D319D7ECF852Q34481843-A01EDF8F-BA4D-4630-808E-C6D9ACAD8EF2Q35048985-6D82BB10-79D4-4D9F-B6E5-1F08F3DC4871Q35085426-AA1102B9-0E11-40C0-A02B-BED5B2537DF0Q35658814-9BD9227C-AC3F-4FB1-BC21-6905FDB7140CQ35792147-18018CED-7BF7-4497-AA4F-2560F9ADB3CAQ35903082-59C24706-A312-4E5A-A4C6-33398A187DE7Q36082536-D04DFA26-0F4A-4A87-99C4-B435AF20B11DQ36120044-D3C96BAE-B8BE-4270-8BFB-CB604D103189Q36482242-7AC803E3-61E8-4E70-B7E0-E2944C6F36CAQ36940906-1E112C35-ED52-41C0-A48B-948547A7E5C7Q37367690-E8B703F3-C869-4B07-9FC7-67BE2A65CBDEQ37600695-31AFEB21-BC6E-47A2-BF61-1B2B24C5AA87Q37721284-F29A1C9A-CA0A-41BD-95AB-D07EED8E75BCQ38310792-79061101-D491-4F6C-8244-219B17F04F1EQ39793286-50AEE0E3-76F9-4DF2-8EE0-78B1274CD3A5Q39793311-3A4B1B14-69A4-4CBD-82A1-24A65792AEDEQ42118261-3A196337-0A1E-42AB-9A01-11BD77F0D763Q42212701-3CC68809-E9F7-424D-A405-4B4E0AB6DC30Q42501631-1A624CD8-B490-4923-8209-7BE7164222B4Q42932767-57BBE189-CBF2-4BD4-99EE-61BB5C40BB96Q43208113-168A0108-2F44-4774-BA3E-578BD8666A79Q44835478-EC079B8A-3BE1-4B83-8A26-F1DED494662BQ45096816-085B3E26-9491-4B63-BE25-AD0E4C9D4F54Q46162500-9191C92D-CF49-4D09-B9AB-FD009D0E6836Q55717949-FC543E00-0DF6-4949-82C2-F6BBFA955FFEQ58804675-E26E08B6-2096-43BD-A2C1-91D0B14FB1E2
P2860
Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition.
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Modulation of plasminogen acti ...... renin-angiotensin inhibition.
@ast
Modulation of plasminogen acti ...... renin-angiotensin inhibition.
@en
Modulation of plasminogen acti ...... renin-angiotensin inhibition.
@nl
type
label
Modulation of plasminogen acti ...... renin-angiotensin inhibition.
@ast
Modulation of plasminogen acti ...... renin-angiotensin inhibition.
@en
Modulation of plasminogen acti ...... renin-angiotensin inhibition.
@nl
prefLabel
Modulation of plasminogen acti ...... renin-angiotensin inhibition.
@ast
Modulation of plasminogen acti ...... renin-angiotensin inhibition.
@en
Modulation of plasminogen acti ...... renin-angiotensin inhibition.
@nl
P2093
P356
P1433
P1476
Modulation of plasminogen acti ...... renin-angiotensin inhibition.
@en
P2093
P2888
P304
P356
10.1038/KI.1997.20
P407
P577
1997-01-01T00:00:00Z
P5875
P6179
1032457534